UT Southwestern Medical Center-Zale Lipshy University Hospital — Dallas, Texas

UT Southwestern Medical Center-Zale Lipshy University Hospital is a clinical research site located in Dallas, Texas, United States 75390.

Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

UT Southwestern Medical Center-Zale Lipshy University Hospital has participated in 2 clinical trials.

Therapeutic areas: Ovarian Cancer, Low-grade Serous Ovarian Cancer, Low-grade Serous Fallopian Tube Cancer.

Sponsors: Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Dallas

Browse all research sites in Texas · View every site in Dallas

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UT Southwestern Medical Center-Zale Lipshy University Hospital?

UT Southwestern Medical Center-Zale Lipshy University Hospital has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UT Southwestern Medical Center-Zale Lipshy University Hospital conducted?

UT Southwestern Medical Center-Zale Lipshy University Hospital has 2 clinical trials on record. Their work covers Ovarian Cancer, Low-grade Serous Ovarian Cancer, Low-grade Serous Fallopian Tube Cancer.

Is UT Southwestern Medical Center-Zale Lipshy University Hospital accredited by Crixeo Clinical Trials?

UT Southwestern Medical Center-Zale Lipshy University Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UT Southwestern Medical Center-Zale Lipshy University Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.